CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products
Rehovot, Israel (ots/PRNewswire) - Potential to receive up to $103 million in upfront and milestone payments, in addition to royalties and other payments CollPlant Biotechnologies (NASDAQ: CLGN) today announced it has entered into a worldwide exclusive development and commercialization agreement for dermal and soft ...
mehr